The growth in this market is driven byhigh sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals,the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.
The report High-performance Liquid Chromatography (HPLC) Market is projected to reach USD 5.7billion by 2025 from USD 4.5billion
in 2020, at a CAGR of 4.6% during the forecast period.
Download PDF Brochure :-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209
Market Segmentation: -
Based on the product,
the market was divided into instruments, consumables, and accessories. The
instrument market is subjected to account for the largest share in the HPLC
market and consumables to growth at the highest rate during the forecast
period. The need to analyze compounds in trace concentration and the extensive
use of the system in forensic institutes and industries such as
pharmaceuticals, food, nutraceuticals, cosmetics, and environmental testing
calls for growth of the segment.
Based onthe application,
the HPLC market is divided into clinical research, diagnostics, forensics, and
other applications. Clinical research is subjected to grow at the highest rate
in the forecast period. A rise in pharmaceutical and biotechnological research
fueled by the need for numerous preclinical and clinical studies performed
during the drug discovery and development processis said to drive the market.
Regional Analysis:-
North America is
expected to account for the largest share of the global HPLC market. Market
growth in this region is driven primarily by the increase in R&D funding,
the growing number of preclinical activities by CROs &pharmaceutical
companies, and the increasing food & agricultural industry in Canada.
Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=117899209
Top Key Players :-
The global HPLC market
is well established owing to the dominance of prominent market players, such as
Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer
(US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi
(Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US),
Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek
(US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).
No comments:
Post a Comment